Biotherapeutic safety

Tissue Cross-Reactivity (TCR) studies are an important component in the safety evaluation of biotherapeutics and antibody-like molecules. They are designed to identify potential off-target binding to human tissues to mitigate risk following systemic exposure, in particular to pharmacologically active antibodies or cytotoxic immunoconjugates.